Entero Therapeutics
- Country
- Ownership
- -
- Employees
- 9
- Market Cap
- -
- Introduction
First Wave Biopharma, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of non-systemic therapies for the treatment of gastrointestinal diseases. The firm involves in therapeutic development pipeline populated with multiple clinical stage programs built around its proprietary technologies, such as Niclosamide, ...
Study to Assess an Enteric Microgranule Formulation of Adrulipase in Patients With Cystic Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-04-11
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 13
- Registration Number
- NCT05719311
- Locations
- 🇺🇸
The Cystic Fibrosis Institute, Northfield, Illinois, United States
🇺🇸Central Florida Pulmonary Group, Orlando, Florida, United States
🇺🇸Childrens Lung Specialists, Las Vegas, Nevada, United States
Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
- First Posted Date
- 2021-04-26
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 166
- Registration Number
- NCT04858425
- Locations
- 🇮🇳
Yashoda Hospital, Secunderabad, Andhra Pradesh, India
🇮🇳SSG Hospital and Medical Institute, Vadodara, Gujarat, India
🇺🇦Municipal Non-profit Enterprise "City Clinical Hospital # 4" of Dnipro City Council, Dnipro, Ukraine
Study of Latiglutenase in T1D/CD Patients
- First Posted Date
- 2021-04-09
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 13
- Registration Number
- NCT04839575
- Locations
- 🇺🇸
Stanford University, Palo Alto, California, United States
Niclosamide in COVID-19
- First Posted Date
- 2020-09-09
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Entero Therapeutics
- Registration Number
- NCT04542434
Niclosamide In Moderate COVID-19
- First Posted Date
- 2020-06-18
- Last Posted Date
- 2022-02-21
- Lead Sponsor
- Entero Therapeutics
- Registration Number
- NCT04436458
OPTION 2: A Trial to Assess the Safety and Efficacy of MS1819 in Enteric Capsules in Patients With Cystic Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2020-05-06
- Last Posted Date
- 2022-09-13
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 27
- Registration Number
- NCT04375878
- Locations
- 🇺🇸
Investigator Site 102, Altamonte Springs, Florida, United States
🇺🇸Investigator Site 111, Wichita, Kansas, United States
🇺🇸Investigator Site 106, Hershey, Pennsylvania, United States
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
- First Posted Date
- 2020-01-28
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 83
- Registration Number
- NCT04243551
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
- Conditions
- Interventions
- First Posted Date
- 2018-11-19
- Last Posted Date
- 2022-06-06
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 41
- Registration Number
- NCT03746483
- Locations
- 🇺🇸
Investigator Site 105, Long Beach, California, United States
🇺🇸Investigator Site 102, Altamonte Springs, Florida, United States
🇺🇸Investigator Site 108, Portland, Maine, United States
A Study of Niclosamide Enemas in Subjects With Active Ulcerative Proctitis or Ulcerative Proctosigmoiditis
- Conditions
- Interventions
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2022-11-29
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 27
- Registration Number
- NCT03521232
- Locations
- 🇮🇹
Tor Vegata, Rome, Italy
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
- First Posted Date
- 2017-01-06
- Last Posted Date
- 2024-08-05
- Lead Sponsor
- Entero Therapeutics
- Target Recruit Count
- 40
- Registration Number
- NCT03011931
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States